What is Acadia Pharmaceuticals's deferred taxes?

Acadia Pharmaceuticals (ACAD) reported deferred taxes of -$94K in Q1 2026.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Acadia Pharmaceuticals ACAD Deferred Taxes

Deferred Taxes at other companies

BiogenBIIB

$23.6M+185%

Neurocrine BiosciencesNBIX

-$61.1M-346%

Catalyst PharmaceuticalCPRX

$2.34M+0.6%

PTC TherapeuticsPTCT

-$10K-600%

TG TherapeuticsTGTX

$3.86M—

Xenon PharmaceuticalsXENE

$447K+137%

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$344K-96.1%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's deferred taxes?: Acadia Pharmaceuticals (ACAD) reported deferred taxes of -$94K in Q1 2026.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.